Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Reader Multi-Case (MRMC) Study for Assessing the Impact of Legit.Health Plus on the Clinical Assessment of Generalized Pustular Psoriasis and Other Skin Conditions by Healthcare Professionals.

NCT07428915 is registered in ClinicalTrials.gov with AI Labs Group S.L as lead sponsor.

NCT NCT07428915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07428915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Reader Multi-Case (MRMC) Study for Assessing the Impact of Legit.Health Plus on the Clinical Assessment of Generalized Pustular Psoriasis and Other Skin Conditions by Healthcare Professionals.
Lead sponsor
AI Labs Group S.L
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
September 15, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne, acne conglobata, acute generalized exanthematous pustulosis, eczema atopic dermatitis, generalized pustular psoriasis (gpp), hidradenitis suppurativa (hs), impetigo, palmoplantar pustulosis, pemphigus vulgaris (pv), plaque psoriasis, pustular psoriasis (pp), seborrheic dermatitis, seborrheic keratoses, tinea corporis